IP Verse

Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (Pcsk9) - EP3666797

PATENT ANALYSIS

Patent Details

Grant Date
May 17, 2023
Company
AMGEN, INC
Oppositions

REGENERON PHARMACEUTICALS, INC.

SANOFI-AVENTIS DEUTSCHLAND GMBH

More patents of Amgen, Inc

EP2301961

EP2445924

EP3666797

Want to monitor this patent?

Feel free to send us a message here and we will get back to you